Valeant Pharmaceuticals International Inc. | Balance Sheet
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
600
366
613
543
797
723
Total Accounts Receivable
1,815
2,076
2,687
2,517
2,130
1,865
Inventories
883
889
1,257
1,061
1,048
934
Other Current Assets
588
801
950
956
771
689
Total Current Assets
3,886
4,132
5,507
5,077
4,746
4,211
Net Property, Plant & Equipment
1,234
1,312
1,442
1,312
1,403
1,353
Intangible Assets
22,600
20,639
41,636
34,678
30,804
25,143
Other Assets
195
167
224
2,316
111
109
Total Assets
27,971
26,305
48,965
43,529
37,497
32,492
ST Debt & Current Portion LT Debt
217
7
839
7
209
Accounts Payable
365
398
434
324
365
Income Tax Payable
105
134
221
213
202
Other Current Liabilities
1,826
2,170
3,819
3,065
3,492
Total Current Liabilities
2,512
2,708
5,313
3,609
4,268
Long-Term Debt
17,163
15,228
30,265
29,845
25,235
Provision for Risks & Charges
172
342
311
379
-
Deferred Taxes
2,264
2,167
5,746
5,288
747
Other Liabilities
571
403
1,144
1,004
870
Total Liabilities
22,737
20,903
42,935
40,271
31,553
Common Equity (Total)
5,119
5,279
5,911
3,152
5,849
Total Shareholders' Equity
5,119
5,279
5,911
3,152
5,849
Total Equity
5,233
5,402
6,030
3,258
5,944
Liabilities & Shareholders' Equity
27,971
26,305
48,965
43,529
37,497
Accumulated Minority Interest
115
122
119
106
95
About Valeant Pharmaceuticals International
View Profile
